hotspot -WSS

hotspot

author：hotspot 2025-10-02 04:08:31 - browse：7

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： After a drawn out lobbying fight, ARPA

knowledge

WSS

Researchers use wearables data and AI to predict preterm birth risk

Goldman Sachs launches $650M fund for life science investments

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Feng Zhang CRISPR delivery startup lays off quarter of staff

Biogen shutters digital health group, ends Apple study, in cost cutting move

Did you have Obamacare on your GOP debate bingo card?

focus

hotspot

hotspot

In Memoriam: Notable people who died in 2023

Senator probes 340B programs at Cleveland Clinic, Bon Secours

In Memoriam: Notable people who died in 2023

The FDA must approve intranasal treatments for anaphylaxis

BioMarin wins approval for gene therapy to treat hemophilia A

Why do women spend more than men on medical expenses?

Medical records are filled with copy

AdventHealth escalates lawsuit against insurance vendor Multiplan

How one medical school became remarkably diverse

A single drug, study failures leave Anavex with nothing but cash

hotspot

Listen: Who gets the credit for GLP

Goldman Sachs launches $650M fund for life science investments

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

JPM: CVS says Medicare Advantage patients are impacting profits

After a drawn out lobbying fight, ARPA

New weight loss drugs work. But how can they best be used?

focus

knowledge

leisure time

hotspot